about
Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patientsAntibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipientsAntibody induction versus corticosteroid induction for liver transplant recipientsGlucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patientsAntibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipientsAntibody induction versus corticosteroid induction for liver transplant recipientsCalcineurin inhibitor minimisation versus continuation of calcineurin inhibitor treatment for liver transplant recipientsConversion of calcineurin inhibitor treatment to target of rapamycin inhibitor treatment versus continuation of calcineurin inhibitor treatment for liver transplant recipientsCalcineurin inhibitor reduction or withdrawal versus continuation of calcineurin inhibitor treatment for liver transplant recipientsImmunosuppressive T cell antibody induction therapy for liver transplant recipientsEffects of chalcone derivatives on players of the immune systemCurrent status of immunosuppression in liver transplantationSuccinct guide to liver transplantation for medical studentsConnexin32 deficiency exacerbates carbon tetrachloride-induced hepatocellular injury and liver fibrosis in miceTransplantation immunology: solid organ and bone marrow.Neurologic complications after liver transplantation.Analysis of infections in the first 3-month after living donor liver transplantationMycophenolate mofetil inhibits hepatitis C virus replication in human hepatic cellsPreparation and in vitro and in vivo characterization of cyclosporin A-loaded, PEGylated chitosan-modified, lipid-based nanoparticles.High frequency of central memory regulatory T cells allows detection of liver recipients at risk of early acute rejection within the first month after transplantation.Enhanced B Cell Alloantigen Presentation and Its Epigenetic Dysregulation in Liver Transplant RejectionImmunomodulating options for liver transplant patients.Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis.Impact of Antibodies That React With Liver Tissue and Donor-Specific Anti-HLA Antibodies in Pediatric Idiopathic Posttransplantation Hepatitis.Renal Function Improvement by Telbivudine in Liver Transplant Recipients with Chronic Kidney Disease.Antifungal prophylaxis with liposomal amphotericin B and caspofungin in high-risk patients after liver transplantation: impact on fungal infections and immune system.Impact of different immunosuppressive regimens on the health-related quality of life following orthotopic liver transplantation.Liver transplantation significantly improves global functioning and cerebral processing.Safety and efficacy of four steroid-minimization protocols in liver transplant recipients: 3-year follow-up in a single center.Efficacy and pharmacokinetics of adefovir dipivoxil liquid suspension in patients with chronic hepatitis B and renal impairment.The influence of immunosuppressants on direct-acting antiviral therapy is dependent on hepatitis C virus genotype.Longterm calcineurin inhibitor therapy and brain function in patients after liver transplantation.Discovery of a latent calcineurin inhibitory peptide from its autoinhibitory domain by docking, dynamic simulation, and in vitro methods.Azathioprine-associated pure red cell aplasia in renal transplant recipients: a report of two cases.Oral granulomatosis-like lesions in liver-transplanted pediatric patients.The impact of immunosuppressant therapy on the recurrence of hepatitis C post-liver transplantation.Alterations in gut microbial function following liver transplantLiver Transplantation in an Adult With Sclerosing Cholangitis due to Multisystem Langerhans Cell Histiocytosis
P2860
Q24187112-FE9942B3-B3CA-40F3-A2B2-36DC7DB209EAQ24194087-F7B0F002-C4F7-4C9E-BAE3-90464A99E3FDQ24194518-B448F2C5-7095-498B-BE04-202B56FA9444Q24194975-4298148B-513A-418A-AD5D-EBFD68405E7CQ24197745-6C122025-EB61-472D-957C-119363F5B905Q24197859-9DF3B1F1-0249-4956-B715-C708CB916FF9Q24201021-37A1124E-7950-4008-9C9B-3AFCF5C9F75BQ24234041-058B9262-51E6-4924-9E4A-1689FA42EFD8Q24234218-D869EEDA-6F2A-41B5-9808-DE479829B0A4Q24235428-C79113A1-3DE9-4EA8-86FE-332FD61DC2FFQ26796454-188B3E4D-73F2-4799-8DCE-BE1187FBE303Q27694591-BF1B95D6-BB04-4340-B0B5-AE79F767FA57Q28075352-28395F9E-4707-4E2F-AE92-D1759CF83E03Q33637151-5E498297-5EF4-4A7A-A978-AB0576B043E4Q33803804-F2EE0E73-8602-47AD-8492-10A4942C85B0Q34655992-990D4973-DA98-4721-9A52-B3D3652E2685Q35915335-DFC6AFF4-8916-49E3-844E-65789F606E68Q36420503-B1554E97-4528-43FC-9324-FDBC5A77B46FQ36617869-A9F1860B-2C18-4E7E-952A-BC4C122B0F13Q36947322-2690A851-1DB4-4977-8CF6-9077CA972D09Q37370835-1072620E-27E2-45B4-BFCD-71A8EA11A45CQ38044761-29C30D39-4F78-420F-8D6A-2A949CFB3F8EQ38939879-9CC5C03A-FA84-4FD6-AD46-D3B27A9BBFADQ39001834-AC3BBF30-3E9E-4FF3-8ACD-BC8CABE0E21CQ40051822-1F2796A8-BED8-40BA-9908-2CA316336366Q40932543-A972C966-DB8A-45A3-9042-D6F8CE57C412Q41376761-BF19B41E-7488-43DC-AAC3-CA84D3247145Q41652612-28D5E138-21DF-42AB-A15B-A894E15E20DDQ43466764-952B4138-45AF-429D-8CF3-C81FCED3CA0AQ44960539-03206352-71AA-49A7-ADBE-E487811D1FF4Q45325199-6FFDFE4D-A5BE-46A4-8BAB-21A8662A3AF1Q47961241-272198D1-3986-48C4-A0B2-29D9B774FEFDQ50264758-D640404D-060A-4484-A54C-A092A66C936DQ50490977-C39BAD06-CCD8-44EB-BBB9-7D3EAF502181Q51232613-E11B920B-5787-417B-BF23-2D9F88E3BA43Q55692477-797DE0DA-A5EE-4904-854D-FDEEECD60D92Q57118481-706C960E-08F0-4DD9-8AD1-2C22A15AC025Q59305022-648FFDA3-04C7-476B-98FA-9772EC71DCD8
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Overview of immunosuppression in liver transplantation.
@en
Overview of immunosuppression in liver transplantation.
@nl
type
label
Overview of immunosuppression in liver transplantation.
@en
Overview of immunosuppression in liver transplantation.
@nl
prefLabel
Overview of immunosuppression in liver transplantation.
@en
Overview of immunosuppression in liver transplantation.
@nl
P2860
P356
P1476
Overview of immunosuppression in liver transplantation.
@en
P2093
Anjana A Pillai
Josh Levitsky
P2860
P304
P356
10.3748/WJG.15.4225
P407
P577
2009-09-01T00:00:00Z